These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 760742)
1. The effect of ageing on the hepatic clearance of propranolol. Castleden CM; George CF Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742 [TBL] [Abstract][Full Text] [Related]
2. No stereoselective first-pass hepatic extraction of propranolol. Jackman GP; McLean AJ; Jennings GL; Bobik A Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of propranolol in the dog. Tse FL; Sanders TM; Reo JP Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706 [TBL] [Abstract][Full Text] [Related]
5. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics. Vu VT; Bai SA; Abramson FP J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749 [TBL] [Abstract][Full Text] [Related]
6. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing. Wells PG; Feely J; Wilkinson GR; Wood AJ Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632 [TBL] [Abstract][Full Text] [Related]
7. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis. Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404 [TBL] [Abstract][Full Text] [Related]
8. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of propranolol: a review. Shand DG Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953 [TBL] [Abstract][Full Text] [Related]
10. Presystemic and systemic glucuronidation of propranolol. Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. Terao N; Shen DD J Pharmacokinet Biopharm; 1984 Oct; 12(5):479-93. PubMed ID: 6520744 [TBL] [Abstract][Full Text] [Related]
12. Direct measurement of propranolol bioavailability during accumulation to steady-state. Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. Bowman SL; Hudson SA; Simpson G; Munro JF; Clements JA Br J Clin Pharmacol; 1986 May; 21(5):529-32. PubMed ID: 3718810 [TBL] [Abstract][Full Text] [Related]
14. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog. Bai SA; Walle UK; Walle T J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163 [TBL] [Abstract][Full Text] [Related]
15. Kinetics and cardiac effects of propranolol in humans. Ochs HR; Grube E; Greenblatt DJ; Knüchel M; Bodem G Klin Wochenschr; 1982 May; 60(10):521-5. PubMed ID: 7098380 [TBL] [Abstract][Full Text] [Related]
16. Effects of route of administration and blood flow on hepatic drug elimination. Shand DG; Kornhauser DM; Wilkinson GR J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129 [TBL] [Abstract][Full Text] [Related]
17. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man. Evans GH; Shand DG Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255 [No Abstract] [Full Text] [Related]
18. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Chidsey CA; Morselli P; Bianchetti G; Morganti A; Leonetti G; Zanchetti A Circulation; 1975 Aug; 52(2):313-8. PubMed ID: 1149212 [TBL] [Abstract][Full Text] [Related]
19. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine. Young CJ; Daneshmend TK; Roberts CJ Gut; 1982 Oct; 23(10):819-23. PubMed ID: 6126422 [TBL] [Abstract][Full Text] [Related]
20. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Walle T; Walle UK; Cowart TD; Conradi EC Clin Pharmacol Ther; 1989 Sep; 46(3):257-63. PubMed ID: 2776391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]